- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03764969
Modification of Goal-directed and Habitual Behavior in Addiction
October 4, 2023 updated by: Central Institute of Mental Health, Mannheim
Modification of the Imbalance Between Goal-directed and Habitual Behavior in Human Addiction
This study aims to examine the modification of the hypothesized imbalance between goal-directed and habitual behavior and its neural correlates in smokers.
Two interventions will be used as add-on trainings to a smoking cessation program.
Study Overview
Status
Completed
Conditions
Detailed Description
In this study, the investigators aim to assess the imbalance between goal-directed and habitual behavior, its neural basis and how it can be differentially modified in treatment-seeking smokers, using two training interventions.
The first intervention is cognitive remediation treatment (CRT), also known as cognitive enhancement therapy, focusing on improving inhibitory control and executive functions.
The second intervention, a computer-based habit-modifying training focusing on implicit drug seeking ("implicit computer-based habit-modifying training", ICHT) uses a conditioning approach through implicit priming and contextual modulation.
Indicators of the imbalance will be examined with respect to reward devaluation, cue reactivity and a pavlovian instrumental transfer (PIT) paradigm.
The investigators hypothesize that both interventions change the balance between goal-directed and habitual behavior but by different mechanisms.
Whereas CRT should directly increase cognitive control, in contrast, ICHT should affect the early processing and the emotional valence of smoking and smoking cues.
Study Type
Interventional
Enrollment (Actual)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Baden-Württemberg
-
Mannheim, Baden-Württemberg, Germany, 68159
- Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- severe tobacco use disorder (TUD) according to DSM-5
- sufficient ability to communicate with investigators and answer questions in both written and verbal format
- ability to provide fully informed consent and to use self-rating scales
Exclusion Criteria:
- severe internal, neurological, and/or psychiatric comorbidities; other Axis I mental disorders other than TUD according to ICD-10 and DSM 5 (except for mild depression, i.e. F32.0, adjustment disorder and specific phobias) in the last 12 months
- history of brain injury
- severe physical diseases
- common exclusion criteria for MRI (e.g. metal, claustrophobia)
- positive drug screening (opioids, benzodiazepines, barbiturates, cocaine, amphetamines)
- psychotropic medication within the last 14 days
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: standard smoking cessation program (SCP)
standard smoking cessation program
|
Each subject will receive standard SCP as group treatment once a week (1 hour) over six weeks.
This group therapy is based on behavioural therapy and a psycho-educational approach (for more details see Batra & Buchkremer 2004), and will be carried out by a qualified therapist.
|
|
Experimental: SCP + CRT
SCP plus cognitive remediation treatment (CRT)
|
Each subject will receive standard SCP as group treatment once a week (1 hour) over six weeks.
This group therapy is based on behavioural therapy and a psycho-educational approach (for more details see Batra & Buchkremer 2004), and will be carried out by a qualified therapist.
Cognitive remediation treatment (CRT) employing a chess-based battery of tasks two times per week over six weeks as a group treatment in our outpatient clinic (60 min duration per session).
|
|
Experimental: SCP + ICHT
SCP plus an implicit computer-based habit-modifying training (ICHT)
|
Each subject will receive standard SCP as group treatment once a week (1 hour) over six weeks.
This group therapy is based on behavioural therapy and a psycho-educational approach (for more details see Batra & Buchkremer 2004), and will be carried out by a qualified therapist.
Implicit computer-based habit-modifying training (ICHT), applied twice a week for six weeks.
In this training, the participants perform a two-part training.
First, a subliminal presentation (20 ms) of negative valenced primes before smoking-cues in context and secondly, a subliminal presentation of positive valenced primes before potentially reinforcing events.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in imbalance between goal-directed and habitual behavior
Time Frame: 2 time points: before and after 6 weeks SCP
|
measured by reward devaluation procedure (Hogarth & Chase 2011)
|
2 time points: before and after 6 weeks SCP
|
|
Change in implicit smoking-related associations
Time Frame: 3 time points: before and after 6 weeks SCP plus after 3 months
|
smoking-related implicit association task (Wiers et al. 2016).
|
3 time points: before and after 6 weeks SCP plus after 3 months
|
|
Change in attentional bias to smoking cues
Time Frame: 3 time points: before and after 6 weeks SCP plus after 3 months
|
smoking-related dot-probe task (Vollstädt-Klein et al. 2009).
|
3 time points: before and after 6 weeks SCP plus after 3 months
|
|
Change in smoking urges
Time Frame: 3 time points: before and after 6 weeks SCP plus after 3 months
|
questionnaire of smoking urges (QSU, Müller et al. 2001)); self-report questionnaire; two subscales: "intention and desire to smoke / anticipation of pleasure from smoking" (range 11 - 77) and "anticipation of relief from negative affect and nicotine withdrawal / urgent and overwhelming desire to smoke" (range 10 - 70) high values represent high craving
|
3 time points: before and after 6 weeks SCP plus after 3 months
|
|
Change in working memory capacity
Time Frame: 3 time points: before and after 6 weeks SCP plus after 3 months
|
Spatial Working Memory task from the Cambridge Automated Neuropsychological Test Automated Battery (Robbins et al. 1994)
|
3 time points: before and after 6 weeks SCP plus after 3 months
|
|
Change in planning ability
Time Frame: 3 time points: before and after 6 weeks SCP plus after 3 months
|
One Touch Stockings of Cambridge task from the Cambridge Automated Neuropsychological Test Automated Battery (Robbins et al. 1994)
|
3 time points: before and after 6 weeks SCP plus after 3 months
|
|
Change in cognitive flexibility
Time Frame: 3 time points: before and after 6 weeks SCP plus after 3 months
|
Internal-External Set Shifting task from the Cambridge Automated Neuropsychological Test Automated Battery (Robbins et al. 1994)
|
3 time points: before and after 6 weeks SCP plus after 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
nicotine consumption
Time Frame: 3 months follow-up
|
self-report
|
3 months follow-up
|
|
Change in neural PIT effect
Time Frame: 2 time points: before and after 6 weeks SCP
|
PIT phase of a choice task (adapted from Hogarth & Chase 2011)
|
2 time points: before and after 6 weeks SCP
|
|
Change in neural cue reactivity
Time Frame: 2 time points: before and after 6 weeks SCP
|
fMRI cue-reactivity task (Vollstädt-Klein et al. 2011)
|
2 time points: before and after 6 weeks SCP
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Herta Flor, Prof. Dr., Central Institute of Mental Health, Mannheim
- Principal Investigator: Sabine Vollstädt-Klein, Prof. Dr., Central Institute of Mental Health, Mannheim
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 7, 2020
Primary Completion (Actual)
June 23, 2023
Study Completion (Actual)
June 23, 2023
Study Registration Dates
First Submitted
November 28, 2018
First Submitted That Met QC Criteria
December 4, 2018
First Posted (Actual)
December 5, 2018
Study Record Updates
Last Update Posted (Actual)
October 5, 2023
Last Update Submitted That Met QC Criteria
October 4, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TRR265 C01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use Disorder
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Cessation | Tobacco Use | Tobacco Use Cessation | Tobacco Dependence | Tobacco AbstinenceUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Nicotine Dependence | Tobacco Dependence | Smoking, Tobacco | Nicotine Use Disorder | Nicotine Dependence, Cigarettes | Smoking, Cigarette | Nicotine Dependence Tobacco Product | Tobacco; Use, Rehabilitation | Smoking (Tobacco) Addiction and other conditionsUnited States
-
University of UtahNational Cancer Institute (NCI)RecruitingTobacco Use | Tobacco Smoking | Tobacco Use Cessation | Tobacco Dependence | Tobacco ChewingUnited States
-
Harvard School of Public Health (HSPH)Beacon Communities; The Community BuildersEnrolling by invitationTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Second Hand Tobacco SmokeUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco DependenceUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); National Institute on Minority Health...CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramCompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Centre for Addiction and Mental HealthCanadian Cancer Society (CCS)RecruitingSmoking Cessation | Tobacco Smoking | Substance Use Disorders | Nicotine Dependence | Nicotine Use DisorderCanada
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
-
Rutgers, The State University of New JerseyNational Institute on Drug Abuse (NIDA)CompletedSchizophrenia | Schizoaffective Disorder | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use CessationUnited States
Clinical Trials on standard smoking cessation program (SCP)
-
Central Institute of Mental Health, MannheimRecruitingTobacco Use DisorderGermany
-
Masonic Cancer Center, University of MinnesotaUniversity of MinnesotaRecruiting
-
Kimber Richter, PhD, MPH, MANational Heart, Lung, and Blood Institute (NHLBI)CompletedSmokingUnited States
-
University of SalernoNot yet recruitingSmoking Cessation | Smoking Behaviors | Smoking Dependence | Smoking Abstinence | Smoking Cessation Intervention | Smoking (Tobacco) Addiction | Smoking E-cigarette | Smoking Addiction | Smoking ( Cigarette)
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Boston Medical CenterCompleted
-
China Medical University HospitalUnknown
-
University of MilanEuropean Institute of Oncology; Fondazione Umberto VeronesiUnknown
-
National Institute on Aging (NIA)Completed
-
National Institute of Neurological Disorders and...CompletedSmoking | ObesityUnited States